Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden

키워드

참고문헌 (45)

1. Lu CH, "Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis", Neurology, 84, pp.2247~2257 (2015)[DOI]
2. Mattsson N, "Association of plasma neurofilament light with neurodegeneration in patients with alzheimer disease", JAMA Neurol, 74, pp.557~566 (2017)[DOI]
3. Rohrer JD, "Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia", Neurology, 87, pp.1329~1336 (2016)[DOI]
4. Pantoni L, "Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges", Lancet Neurol, 9, pp.689~701 (2010)[DOI]
5. Gattringer T, "Serum neurofilament light is sensitive to active cerebral small vessel disease", Neurology, 89, pp.2108~2114 (2017)[DOI]
6. Traenka C, "Serum neurofilament light chain levels are associated with clinical characteristics and outcome in patients with cervical artery dissection", Cerebrovasc Dis, 40, pp.222~227 (2015)[DOI]
7. Jonsson M, "Cerebrospinal fluid biomarkers of white matter lesions: cross-sectional results from the LADIS study", Eur J Neurol, 17, pp.377~382 (2010)[DOI]
8. Duering M, "Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease", Brain, 136, pp.2717~2726 (2013)[DOI]
9. van Norden AG, "Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol", BMC Neurol, 11, pp.29~ (2011)[DOI]
10. Harrison JK, "Assessment scales in stroke: clinimetric and clinical considerations", Clin Interv Aging, 8, pp.201~211 (2013)
11. Zieren N, "Education modifies the relation of vascular pathology to cognitive function: cognitive reserve in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Neurobiol Aging, 34, pp.400~407 (2013)[DOI]
12. Charlton RA, "The cognitive profiles of CADASIL and sporadic small vessel disease", Neurology, 66, pp.1523~1526 (2006)[DOI]
13. Tombaugh TN, "Trail Making Test A and B: normative data stratified by age and education", Arch Clin Neuropsychol, 19, pp.203~214 (2004)[DOI]
14. Van Der Elst W, "Assessment of information processing in working memory in applied settings: the paper and pencil memory scanning test", Psychol Med, 37, pp.1335~1344 (2007)[DOI]
15. Van der Elst W, "The Concept Shifting Test: adult normative data", Psychol Assess, 18, pp.424~432 (2006)[DOI]
16. Norgren N, "Monoclonal antibodies selective for low molecular weight neurofilaments", Hybrid Hybridomics, 21, pp.53~59 (2002)[DOI]
17. Baykara E, "A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms", Ann Neurol, 80, pp.581~592 (2016)[DOI]
18. Wollenweber FA, "Cortical superficial siderosis in different types of cerebral small vessel disease", Stroke, 48, pp.1404~1407 (2017)[DOI]
19. Behrens TE, "Probabilistic diffusion tractography with multiple fibre orientations: what can we gain?", Neuroimage, 34, pp.144~155 (2007)[DOI]
20. Behrens TE, "Characterization and propagation of uncertainty in diffusion-weighted MR imaging", Magn Reson Med, 50, pp.1077~1088 (2003)[DOI]
21. Smith SM, "Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data", Neuroimage, 31, pp.1487~1505 (2006)[DOI]
22. R Core Team, "A Language and Environment for Statistical Computing", R Foundation for Statistical Computing, ~ (2016)
23. Sing T, "ROCR: visualizing classifier performance in R", Bioinformatics, 21, pp.3940~3941 (2005)[DOI]
24. Williams DA, "Generalized linear model diagnostics using the deviance and single case deletions", J R Stat Soc Ser C Appl Stat, 36, pp.181~191 (1987)
25. "Ordinal: regression models for ordinal data" (2015)[URL]
26. "Glmnetcr: fit a penalized constrained continuation ratio model for predicting an ordinal response" (2017)[URL]
27. Kuhle J, "A comparative study of CSF neurofilament light and heavy chain protein in MS", Mult Scler, 19, pp.1597~1603 (2013)[DOI]
28. Gaiottino J, "Increased neurofilament light chain blood levels in neurodegenerative neurological diseases", PLoS One, 8, pp.e75091~ (2013)[DOI]
29. Benjamin P, "Progression of MRI markers in cerebral small vessel disease: sample size considerations for clinical trials", J Cereb Blood Flow Metab, 36, pp.228~240 (2016)[DOI]
30. de Laat KF, "Diffusion tensor imaging and gait in elderly persons with cerebral small vessel disease", Stroke, 42, pp.373~379 (2011)[DOI]
31. Voineskos AN, "Age-related decline in white matter tract integrity and cognitive performance: a DTI tractography and structural equation modeling study", Neurobiol Aging, 33, pp.21~34 (2012)[DOI]
32. Pearce LA, "Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial", Lancet Neurol, 13, pp.1177~1185 (2014)[DOI]
33. Haller S, "Head motion parameters in fMRI differ between patients with mild cognitive impairment and Alzheimer disease versus elderly control subjects", Brain Topogr, 27, pp.801~807 (2014)[DOI]
34. Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration", Lancet Neurol, 12, pp.822~838 (2013)[DOI]
35. De Guio F, "Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease", J Cereb Blood Flow Metab, 36, pp.1319~1337 (2016)[DOI]
36. Nagai M, "Association of prothrombotic status with markers of cerebral small vessel disease in elderly hypertensive patients", Am J Hypertens, 25, pp.1088~1094 (2012)[DOI]
37. Satizabal CL, "Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study", Neurology, 78, pp.720~727 (2012)[DOI]
38. van Dijk EJ, "C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study", Circulation, 112, pp.900~905 (2005)[DOI]
39. Markus HS, "Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study", Stroke, 36, pp.1410~1414 (2005)[DOI]
40. Vilar-Bergua A, "N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease", Neurology, 87, pp.2533~2539 (2016)[DOI]
41. Wiseman SJ, "Plasma biomarkers of inflammation, endothelial function and hemostasis in cerebral small vessel disease", Cerebrovasc Dis, 40, pp.157~164 (2015)[DOI]
42. Schmidt R, "C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study", Stroke, 37, pp.2910~2916 (2006)[DOI]
43. Disanto G, "Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome", J Neurol Neurosurg Psychiatry, 87, pp.126~129 (2016)[DOI]
44. Kuhle J, "Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity", Mult Scler, 22, pp.1550~1559 (2016)[DOI]
45. Kuhle J, "Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa", Clin Chem Lab Med, 54, pp.1655~1661 (2016)

관련 논문AI추천